|
Enrolled population | Interventional procedure | Outcomes | Ref. |
|
Melatonin |
|
30 newborns: 10 sepsis/10 sepsis and melatonin treatment/10 controls | Melatonin, 20 mg/kg orally within 12 hours of sepsis diagnosis (2 doses, 10 mg/kg each, separated by 1-hour interval) | Reduced MDA + 4-HDA at 1 and 4 hours after treatment in septic treated versus septic untreated infants Reduced WBC count, ANC, CRP 24 hours after treatment in septic treated versus septic untreated infants | [63] |
|
40 newborns: 20 sepsis/20 sepsis and melatonin treatment | Melatonin, 20 mg/kg orally, single dose | Reduced CRP and better clinical improvement at 24 and 72 hours after treatment in treated versus untreated infants | [99] |
|
50 newborns: 25 sepsis/25 sepsis and melatonin treatment | Melatonin, 20 mg/kg orally, single dose | Reduced sepsis score at 24 and 48 hours after treatment in treated versus untreated infants | [100] |
|
Pentoxifylline |
|
120 newborns: 60 LOS/60 LOS and pentoxifylline treatment | Pentoxifylline, 5 mg/kg/h IV for 6 hours for 6 days | Reduced TNF-alpha, vasopressor need, duration of respiratory support, duration of antibiotics, hospital stay, incidence of DIC, and thrombocytopenia in treated versus untreated infants No differences in mortality | [105] |
|
Meta-analysis of 6 randomized or quasi-randomized trials; 416 newborns | Pentoxifylline, continuous IV infusion, different dosing regimens | Reduced all-cause mortality, reduced hospital stay in septic treated versus untreated septic infants Reduced mortality in the subgroup of preterm newborns, proven sepsis, and Gram-negative sepsis in septic treated versus untreated septic infants | [106] |
|